Compounds > clofibrate
Page last updated: 2024-10-25

clofibrate and Dyslipidemias

clofibrate has been researched along with Dyslipidemias in 2 studies

angiokapsul: contains clofibrate & insoitolnicotinate

Dyslipidemias: Abnormalities in the serum levels of LIPIDS, including overproduction or deficiency. Abnormal serum lipid profiles may include high total CHOLESTEROL, high TRIGLYCERIDES, low HIGH DENSITY LIPOPROTEIN CHOLESTEROL, and elevated LOW DENSITY LIPOPROTEIN CHOLESTEROL.

Research Excerpts

ExcerptRelevanceReference
"Hypothyroidism is common in the elderly, especially among women."1.33[Hypolipidemic therapy in special situations: hypothyroidism and liver disease]. ( Cesena, FH; Luz, PL; Xavier, HT, 2005)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sando, KR1
Knight, M1
Cesena, FH1
Xavier, HT1
Luz, PL1

Reviews

1 review available for clofibrate and Dyslipidemias

ArticleYear
Nonstatin therapies for management of dyslipidemia: a review.
    Clinical therapeutics, 2015, Oct-01, Volume: 37, Issue:10

    Topics: Anticholesteremic Agents; Cardiovascular Diseases; Cholesterol Ester Transfer Proteins; Cholesterol,

2015

Other Studies

1 other study available for clofibrate and Dyslipidemias

ArticleYear
[Hypolipidemic therapy in special situations: hypothyroidism and liver disease].
    Arquivos brasileiros de cardiologia, 2005, Volume: 85 Suppl 5

    Topics: Age Factors; Azetidines; Clofibrate; Drug Interactions; Dyslipidemias; Ezetimibe; Female; Humans; Hy

2005